Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

FactSet (FDS) Stock Slides After Q1 FY2026 Earnings: Revenue Beat, Guidance Reaffirmed, and a $1 Billion Buyback — What Investors Are Watching (Dec. 18, 2025)

FactSet (FDS) Stock Slides After Q1 FY2026 Earnings: Revenue Beat, Guidance Reaffirmed, and a $1 Billion Buyback — What Investors Are Watching (Dec. 18, 2025)

FactSet Research Systems Inc. (NYSE: FDS) delivered a “beat-and-dip” kind of morning on Thursday, December 18, 2025: the company topped Wall Street expectations for revenue and adjusted earnings in its fiscal first quarter, reaffirmed full‑year guidance, and expanded its share
Fermi Inc (FRMI) Stock on Dec. 18, 2025: Amazon-Tenant Claims Clash With Company Denial as Analysts Recut Targets After Project Matador Setback

Fermi Inc (FRMI) Stock on Dec. 18, 2025: Amazon-Tenant Claims Clash With Company Denial as Analysts Recut Targets After Project Matador Setback

Fermi Inc (NASDAQ & LSE: FRMI) is having the kind of week that turns a normal stock chart into modern art: sharp gaps, headline-driven swings, and investors trying to separate what’s confirmed from what’s merely energetic speculation. On December 18,
Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)

Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) stock slid sharply on Thursday, December 18, 2025, after a regulatory filing revealed a leadership transition involving the company’s Chief Medical and Development Officer. In trading, CRNX fell roughly 8% to around the mid‑$40s, with
1 318 319 320 321 322 587
Go toTop